MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.
- DOI
- 10.26355/eurrev_202109_26782
- Published
- 2021 Sep
- Container
- European review for medical and pharmacological sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_202109_26782,
title = {MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.},
author = {Xiao Y and Zhang SJ and Yan X and Wu C and Liu QW and Dong HX and Wang LJ and Hu Y},
year = {2021},
journal = {European review for medical and pharmacological sciences},
doi = {10.26355/eurrev_202109_26782},
url = {https://doi.org/10.26355/eurrev_202109_26782}
}RIS
TY - JOUR TI - MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7. AU - Xiao Y AU - Zhang SJ AU - Yan X AU - Wu C AU - Liu QW AU - Dong HX AU - Wang LJ AU - Hu Y PY - 2021 JO - European review for medical and pharmacological sciences DO - 10.26355/eurrev_202109_26782 UR - https://doi.org/10.26355/eurrev_202109_26782 ER -
APA
Y, X., SJ, Z., X, Y., C, W., QW, L., HX, D., LJ, W., & Y, H. (2021). MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_202109_26782
Source records
- pubmed · retrieved 2026-09-25T12:53:57.761Z